BioMedha is a UK-based pre-clinical CRO providing in vitro biology drug discovery expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements (Assay development & Screening) of the early stage drug discovery process such as:
# Whole blood and primary cell assays
# Mitochondrial function and toxicity
# Drug combination studies
# Cell health and Cytotoxicity assays
# Functional and expression studies
# Biochemical assays
BioMedha offers bespoke, high-quality, cost effective services tailored for client needs. We work on either a FTE or fee-for-service basis at the most competitive rates. Experienced scientists are assigned to work on a specified project to deliver impactful results in a timely manner.
